{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:55:19Z","timestamp":1789779319707,"version":"4.0.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,10,10]],"date-time":"2013-10-10T00:00:00Z","timestamp":1381363200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s00198-013-2498-z","type":"journal-article","created":{"date-parts":[[2013,10,9]],"date-time":"2013-10-09T09:13:53Z","timestamp":1381310033000},"page":"121-129","source":"Crossref","is-referenced-by-count":70,"title":["\u03b2-adrenergic receptor antagonists and fracture risk: a meta-analysis of selectivity, gender, and site-specific effects"],"prefix":"10.1007","volume":"25","author":[{"given":"K. A.","family":"Toulis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Hemming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Stergianos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Nirantharakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. P.","family":"Bilezikian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,10]]},"reference":[{"key":"2498_CR1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0092-8674(00)81558-5","volume":"100","author":"P Ducy","year":"2000","unstructured":"Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G (2000) Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100:197\u2013207","journal-title":"Cell"},{"key":"2498_CR2","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1210\/en.2010-0881","volume":"152","author":"Y Ma","year":"2011","unstructured":"Ma Y, Nyman JS, Tao H, Moss HH, Yang X, Elefteriou F (2011) Beta2-adrenergic receptor signaling in osteoblasts contributes to the catabolic effect of glucocorticoids on bone. Endocrinology 152:1412\u20131422","journal-title":"Endocrinology"},{"key":"2498_CR3","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.bone.2008.01.005","volume":"42","author":"S Takeda","year":"2008","unstructured":"Takeda S, Karsenty G (2008) Molecular bases of the sympathetic regulation of bone mass. Bone 42:837\u2013840","journal-title":"Bone"},{"key":"2498_CR4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0092-8674(02)01049-8","volume":"111","author":"S Takeda","year":"2002","unstructured":"Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G (2002) Leptin regulates bone formation via the sympathetic nervous system. Cell 111:305\u2013317","journal-title":"Cell"},{"key":"2498_CR5","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nature03398","volume":"434","author":"F Elefteriou","year":"2005","unstructured":"Elefteriou F, Ahn JD, Takeda S, Starbuck M, Yang X, Liu X, Kondo H, Richards WG, Bannon TW, Noda M, Clement K, Vaisse C, Karsenty G (2005) Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434:514\u2013520","journal-title":"Nature"},{"key":"2498_CR6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00223-007-9015-3","volume":"80","author":"MS Patel","year":"2007","unstructured":"Patel MS, Elefteriou F (2007) The new field of neuroskeletal biology. Calcif Tissue Int 80:337\u2013347","journal-title":"Calcif Tissue Int"},{"key":"2498_CR7","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1007\/s00018-005-5175-3","volume":"62","author":"F Elefteriou","year":"2005","unstructured":"Elefteriou F (2005) Neuronal signaling and the regulation of bone remodeling. Cell Mol Life Sci 62:2339\u20132349","journal-title":"Cell Mol Life Sci"},{"key":"2498_CR8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.abb.2008.03.016","volume":"473","author":"F Elefteriou","year":"2008","unstructured":"Elefteriou F (2008) Regulation of bone remodeling by the central and peripheral nervous system. Arch Biochem Biophys 473:231\u2013236","journal-title":"Arch Biochem Biophys"},{"key":"2498_CR9","doi-asserted-by":"crossref","first-page":"174","DOI":"10.14310\/horm.2002.1308","volume":"10","author":"KA Toulis","year":"2011","unstructured":"Toulis KA, Anastasilakis AD, Polyzos SA, Makras P (2011) Targeting the osteoblast: approved and experimental anabolic agents for the treatment of osteoporosis. Horm (Athens) 10:174\u2013195","journal-title":"Horm (Athens)"},{"key":"2498_CR10","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.ehj.2004.06.002","volume":"25","author":"J Lopez-Sendon","year":"2004","unstructured":"Lopez-Sendon J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H, Tendera M, Waagstein F, Kjekshus J, Lechat P, Torp-Pedersen C (2004) Expert consensus document on beta-adrenergic receptor blockers. Eur Heart J 25:1341\u20131362","journal-title":"Eur Heart J"},{"key":"2498_CR11","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1365-2796.2006.01695.x","volume":"260","author":"M Wiens","year":"2006","unstructured":"Wiens M, Etminan M, Gill SS, Takkouche B (2006) Effects of antihypertensive drug treatments on fracture outcomes: a meta-analysis of observational studies. J Intern Med 260:350\u2013362","journal-title":"J Intern Med"},{"key":"2498_CR12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/01.hjh.0000203845.26690.cb","volume":"24","author":"L Rejnmark","year":"2006","unstructured":"Rejnmark L, Vestergaard P, Mosekilde L (2006) Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case\u2013control study. J Hypertens 24:581\u2013589","journal-title":"J Hypertens"},{"key":"2498_CR13","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.bone.2010.10.170","volume":"48","author":"S Yang","year":"2011","unstructured":"Yang S, Nguyen ND, Center JR, Eisman JA, Nguyen TV (2011) Association between beta-blocker use and fracture risk: the Dubbo Osteoporosis Epidemiology Study. Bone 48:451\u2013455","journal-title":"Bone"},{"key":"2498_CR14","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s00198-007-0354-8","volume":"18","author":"C Meisinger","year":"2007","unstructured":"Meisinger C, Heier M, Lang O, Doring A (2007) Beta-blocker use and risk of fractures in men and women from the general population: the MONICA\/KORA Augsburg cohort study. Osteoporos Int 18:1189\u20131195","journal-title":"Osteoporos Int"},{"key":"2498_CR15","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.bone.2007.01.006","volume":"40","author":"N Bonnet","year":"2007","unstructured":"Bonnet N, Gadois C, McCloskey E, Lemineur G, Lespessailles E, Courteix D, Benhamou CL (2007) Protective effect of beta blockers in postmenopausal women: influence on fractures, bone density, micro and macroarchitecture. Bone 40:1209\u20131216","journal-title":"Bone"},{"key":"2498_CR16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00223-006-0213-1","volume":"80","author":"F Vries de","year":"2007","unstructured":"de Vries F, Souverein PC, Cooper C, Leufkens HG, van Staa TP (2007) Use of beta-blockers and the risk of hip\/femur fracture in the United Kingdom and The Netherlands. Calcif Tissue Int 80:69\u201375","journal-title":"Calcif Tissue Int"},{"key":"2498_CR17","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/jbmr.356","volume":"26","author":"DH Solomon","year":"2011","unstructured":"Solomon DH, Mogun H, Garneau K, Fischer MA (2011) Risk of fractures in older adults using antihypertensive medications. J Bone Miner Res 26:1561\u20131567","journal-title":"J Bone Miner Res"},{"key":"2498_CR18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/BF03654781","volume":"23","author":"M Sosa","year":"2011","unstructured":"Sosa M, Saavedra P, Gomez de Tejada MJ, Mosquera J, Perez-Cano R, Olmos JM, Munoz-Torres M, Amerigo MJ, Moro MJ, Diaz-Curiel M, Alegre J, Malouf J, Del Pino J, Nogues X, Torrijos A (2011) Beta-blocker use is associated with fragility fractures in postmenopausal women with coronary heart disease. Aging Clin Exp Res 23:112\u2013117","journal-title":"Aging Clin Exp Res"},{"key":"2498_CR19","doi-asserted-by":"crossref","unstructured":"Song HJ, Lee J, Kim YJ, Jung SY, Kim HJ, Choi NK, Park BJ 2012 beta1 selectivity of beta-blockers and reduced risk of fractures in elderly hypertension patients. Bone","DOI":"10.1016\/j.bone.2012.08.126"},{"key":"2498_CR20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/01.blo.0000200242.52802.6d","volume":"443","author":"S Turker","year":"2006","unstructured":"Turker S, Karatosun V, Gunal I (2006) Beta-blockers increase bone mineral density. Clin Orthop Relat Res 443:73\u201374","journal-title":"Clin Orthop Relat Res"},{"key":"2498_CR21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archinte.166.2.241","volume":"166","author":"BF Gage","year":"2006","unstructured":"Gage BF, Birman-Deych E, Radford MJ, Nilasena DS, Binder EF (2006) Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of Atrial Fibrillation 2. Arch Intern Med 166:241\u2013246","journal-title":"Arch Intern Med"},{"key":"2498_CR22","first-page":"105","volume":"8","author":"IR Reid","year":"2008","unstructured":"Reid IR (2008) Effects of beta-blockers on fracture risk. J Musculoskelet Neuronal Interact 8:105\u2013110","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"2498_CR23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00223-012-9671-9","volume":"92","author":"K Ilic","year":"2013","unstructured":"Ilic K, Obradovic N, Vujasinovic-Stupar N (2013) The relationship among hypertension, antihypertensive medications, and osteoporosis: a narrative review. Calcif Tissue Int 92:217\u2013227","journal-title":"Calcif Tissue Int"},{"key":"2498_CR24","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1001\/jama.292.11.1326","volume":"292","author":"RG Schlienger","year":"2004","unstructured":"Schlienger RG, Kraenzlin ME, Jick SS, Meier CR (2004) Use of beta-blockers and risk of fractures. JAMA 292:1326\u20131332","journal-title":"JAMA"},{"key":"2498_CR25","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bone.2009.04.236","volume":"45","author":"M Peacock","year":"2009","unstructured":"Peacock M, Buckwalter KA, Persohn S, Hangartner TN, Econs MJ, Hui S (2009) Race and sex differences in bone mineral density and geometry at the femur. Bone 45:218\u2013225","journal-title":"Bone"},{"key":"2498_CR26","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1359\/jbmr.040916","volume":"19","author":"BL Riggs","year":"2004","unstructured":"Riggs BL, Melton Iii LJ III, Robb RA, Camp JJ, Atkinson EJ, Peterson JM, Rouleau PA, McCollough CH, Bouxsein ML, Khosla S (2004) Population-based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites. J Bone Miner Res 19:1945\u20131954","journal-title":"J Bone Miner Res"},{"key":"2498_CR27","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1359\/JBMR.050916","volume":"21","author":"S Khosla","year":"2006","unstructured":"Khosla S, Riggs BL, Atkinson EJ, Oberg AL, McDaniel LJ, Holets M, Peterson JM, Melton LJ 3rd (2006) Effects of sex and age on bone microstructure at the ultradistal radius: a population-based noninvasive in vivo assessment. J Bone Miner Res 21:124\u2013131","journal-title":"J Bone Miner Res"},{"key":"2498_CR28","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.bone.2009.05.002","volume":"45","author":"M Peacock","year":"2009","unstructured":"Peacock M, Koller DL, Lai D, Hui S, Foroud T, Econs MJ (2009) Bone mineral density variation in men is influenced by sex-specific and non sex-specific quantitative trait loci. Bone 45:443\u2013448","journal-title":"Bone"},{"key":"2498_CR29","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/oxfordjournals.aje.a116237","volume":"135","author":"S Greenland","year":"1992","unstructured":"Greenland S, Longnecker MP (1992) Methods for trend estimation from summarized dose\u2013response data, with applications to meta-analysis. Am J Epidemiol 135:1301\u20131309","journal-title":"Am J Epidemiol"},{"key":"2498_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta9260","volume":"9","author":"AM Glenny","year":"2005","unstructured":"Glenny AM, Altman DG, Song F, Sakarovitch C, Deeks JJ, D\u2019Amico R, Bradburn M, Eastwood AJ (2005) Indirect comparisons of competing interventions. Health Technol Assess 9:1\u2013134, iii-iv","journal-title":"Health Technol Assess"},{"key":"2498_CR31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1359\/jbmr.0301214","volume":"19","author":"JA Pasco","year":"2004","unstructured":"Pasco JA, Henry MJ, Sanders KM, Kotowicz MA, Seeman E, Nicholson GC (2004) Beta-adrenergic blockers reduce the risk of fracture partly by increasing bone mineral density: Geelong Osteoporosis Study. J Bone Miner Res 19:19\u201324","journal-title":"J Bone Miner Res"},{"key":"2498_CR32","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1359\/JBMR.041202","volume":"20","author":"IR Reid","year":"2005","unstructured":"Reid IR, Gamble GD, Grey AB, Black DM, Ensrud KE, Browner WS, Bauer DC (2005) beta-Blocker use, BMD, and fractures in the study of osteoporotic fractures. J Bone Miner Res 20:613\u2013618","journal-title":"J Bone Miner Res"},{"key":"2498_CR33","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00223-004-0222-x","volume":"75","author":"L Rejnmark","year":"2004","unstructured":"Rejnmark L, Vestergaard P, Kassem M, Christoffersen BR, Kolthoff N, Brixen K, Mosekilde L (2004) Fracture risk in perimenopausal women treated with beta-blockers. Calcif Tissue Int 75:365\u2013372","journal-title":"Calcif Tissue Int"},{"key":"2498_CR34","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1532-5415.2005.53178_7.x","volume":"53","author":"R Levasseur","year":"2005","unstructured":"Levasseur R, Dargent-Molina P, Sabatier JP, Marcelli C, Breart G (2005) Beta-blocker use, bone mineral density, and fracture risk in older women: results from the Epidemiologie de l\u2019Osteoporose prospective study. J Am Geriatr Soc 53:550\u2013552","journal-title":"J Am Geriatr Soc"},{"key":"2498_CR35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2796.1991.tb00302.x","volume":"229","author":"J Jensen","year":"1991","unstructured":"Jensen J, Nielsen LH, Lyhne N, Hallas J, Brosen K, Gram LF (1991) Drugs and femoral neck fracture: a case\u2013control study. J Intern Med 229:29\u201333","journal-title":"J Intern Med"},{"key":"2498_CR36","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S8756-3282(01)00614-7","volume":"29","author":"TP Staa van","year":"2001","unstructured":"van Staa TP, Dennison EM, Leufkens HG, Cooper C (2001) Epidemiology of fractures in England and Wales. Bone 29:517\u2013522","journal-title":"Bone"},{"key":"2498_CR37","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.bone.2011.07.025","volume":"49","author":"M Bazelier","year":"2012","unstructured":"Bazelier M, de Boer A, de Vries F (2012) Acid suppressants and hip fracture: duplicate publication bias? Bone 49:920, author reply 921","journal-title":"Bone"},{"key":"2498_CR38","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.abb.2008.11.012","volume":"482","author":"SJ Aitken","year":"2009","unstructured":"Aitken SJ, Landao-Bassonga E, Ralston SH, Idris AI (2009) Beta2-adrenoreceptor ligands regulate osteoclast differentiation in vitro by direct and indirect mechanisms. Arch Biochem Biophys 482:96\u2013103","journal-title":"Arch Biochem Biophys"},{"key":"2498_CR39","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00223-010-9421-9","volume":"88","author":"H Kondo","year":"2011","unstructured":"Kondo H, Togari A (2011) Continuous treatment with a low-dose beta-agonist reduces bone mass by increasing bone resorption without suppressing bone formation. Calcif Tissue Int 88:23\u201332","journal-title":"Calcif Tissue Int"},{"key":"2498_CR40","doi-asserted-by":"crossref","first-page":"17767","DOI":"10.1073\/pnas.1109402108","volume":"108","author":"M Nagao","year":"2011","unstructured":"Nagao M, Feinstein TN, Ezura Y, Hayata T, Notomi T, Saita Y, Hanyu R, Hemmi H, Izu Y, Takeda S, Wang K, Rittling S, Nakamoto T, Kaneko K, Kurosawa H, Karsenty G, Denhardt DT, Vilardaga JP, Noda M (2011) Sympathetic control of bone mass regulated by osteopontin. Proc Natl Acad Sci U S A 108:17767\u201317772","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2498_CR41","doi-asserted-by":"crossref","first-page":"7433","DOI":"10.1073\/pnas.1109036109","volume":"109","author":"R Hanyu","year":"2012","unstructured":"Hanyu R, Wehbi VL, Hayata T, Moriya S, Feinstein TN, Ezura Y, Nagao M, Saita Y, Hemmi H, Notomi T, Nakamoto T, Schipani E, Takeda S, Kaneko K, Kurosawa H, Karsenty G, Kronenberg HM, Vilardaga JP, Noda M (2012) Anabolic action of parathyroid hormone regulated by the beta2-adrenergic receptor. Proc Natl Acad Sci U S A 109:7433\u20137438","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2498_CR42","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1111\/j.1476-5381.2011.01686.x","volume":"165","author":"WF Rodrigues","year":"2012","unstructured":"Rodrigues WF, Madeira MF, da Silva TA, Clemente-Napimoga JT, Miguel CB, Dias-da-Silva VJ, Barbosa-Neto O, Lopes AH, Napimoga MH (2012) Low dose of propranolol down-modulates bone resorption by inhibiting inflammation and osteoclast differentiation. Br J Pharmacol 165:2140\u20132151","journal-title":"Br J Pharmacol"},{"key":"2498_CR43","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/jcp.21564","volume":"217","author":"N Bonnet","year":"2008","unstructured":"Bonnet N, Benhamou CL, Malaval L, Goncalves C, Vico L, Eder V, Pichon C, Courteix D (2008) Low dose beta-blocker prevents ovariectomy-induced bone loss in rats without affecting heart functions. J Cell Physiol 217:819\u2013827","journal-title":"J Cell Physiol"},{"key":"2498_CR44","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/jbmr.1594","volume":"27","author":"DD Pierroz","year":"2012","unstructured":"Pierroz DD, Bonnet N, Bianchi EN, Bouxsein ML, Baldock PA, Rizzoli R, Ferrari SL (2012) Deletion of beta-adrenergic receptor 1, 2, or both leads to different bone phenotypes and response to mechanical stimulation. J Bone Miner Res 27:1252\u20131262","journal-title":"J Bone Miner Res"},{"key":"2498_CR45","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/pds.1318","volume":"16","author":"F Vries de","year":"2007","unstructured":"de Vries F, Pouwels S, Bracke M, Leufkens HG, Cooper C, Lammers JW, van Staa TP (2007) Use of beta-2 agonists and risk of hip\/femur fracture: a population-based case\u2013control study. Pharmacoepidemiol Drug Saf 16:612\u2013619","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2498_CR46","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1097\/01.ASN.0000101240.47747.7F","volume":"14","author":"CP Schmitt","year":"2003","unstructured":"Schmitt CP, Obry J, Feneberg R, Veldhuis JD, Mehls O, Ritz E, Schaefer F (2003) Beta1-adrenergic blockade augments pulsatile PTH secretion in humans. J Am Soc Nephrol 14:3245\u20133250","journal-title":"J Am Soc Nephrol"},{"key":"2498_CR47","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1210\/jc.2011-3055","volume":"97","author":"SR Majumdar","year":"2012","unstructured":"Majumdar SR, Ezekowitz JA, Lix LM, Leslie WD (2012) Heart failure is a clinically and densitometrically independent risk factor for osteoporotic fractures: population-based cohort study of 45,509 subjects. J Clin Endocrinol Metab 97:1179\u20131186","journal-title":"J Clin Endocrinol Metab"},{"key":"2498_CR48","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0002-8703(80)90112-X","volume":"100","author":"JM Cruickshank","year":"1980","unstructured":"Cruickshank JM (1980) The clinical importance of cardioselectivity and lipophilicity in beta blockers. Am Heart J 100:160\u2013178","journal-title":"Am Heart J"},{"key":"2498_CR49","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.bone.2012.07.013","volume":"51","author":"S Yang","year":"2012","unstructured":"Yang S, Nguyen ND, Eisman JA, Nguyen TV (2012) Association between beta-blockers and fracture risk: a Bayesian meta-analysis. Bone 51:969\u2013974","journal-title":"Bone"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-013-2498-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-013-2498-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-013-2498-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T15:13:46Z","timestamp":1716045226000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-013-2498-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,10]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["2498"],"URL":"https:\/\/doi.org\/10.1007\/s00198-013-2498-z","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,10]]}}}